Jpmorgan Chase & CO Conmed Corp Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Conmed Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 264,068 shares of CNMD stock, worth $16.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
264,068
Previous 424,746 37.83%
Holding current value
$16.2 Million
Previous $30.5 Million 40.84%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$61.81 - $77.54 $9.93 Million - $12.5 Million
-160,678 Reduced 37.83%
264,068 $18.1 Million
Q3 2024

Dec 26, 2024
BUY
$64.09 - $76.92 $7.11 Million - $8.53 Million
110,951 Added 35.36%
424,746 $30.5 Million
Q3 2024

Nov 08, 2024
BUY
$64.09 - $76.92 $7.11 Million - $8.53 Million
110,951 Added 35.36%
424,746 $30.5 Million
Q2 2024

Dec 26, 2024
SELL
$61.9 - $80.36 $6.87 Million - $8.92 Million
-110,951 Reduced 26.12%
313,795 $21.8 Million
Q2 2024

Aug 12, 2024
SELL
$61.9 - $80.36 $8.4 Million - $10.9 Million
-135,658 Reduced 30.18%
313,795 $21.8 Million
Q1 2024

Dec 26, 2024
BUY
$75.36 - $112.51 $1.86 Million - $2.78 Million
24,707 Added 5.82%
449,453 $36 Million
Q1 2024

May 10, 2024
BUY
$75.36 - $112.51 $1.36 Million - $2.04 Million
18,097 Added 4.2%
449,453 $36 Million
Q4 2023

Dec 26, 2024
BUY
$91.3 - $115.05 $603,493 - $760,480
6,610 Added 1.56%
431,356 $47.2 Million
Q4 2023

Feb 12, 2024
SELL
$91.3 - $115.05 $7.8 Million - $9.83 Million
-85,398 Reduced 16.53%
431,356 $47.2 Million
Q3 2023

Nov 14, 2023
SELL
$97.55 - $135.91 $45.7 Million - $63.7 Million
-468,643 Reduced 47.56%
516,754 $52.1 Million
Q2 2023

Aug 11, 2023
SELL
$102.55 - $136.38 $3.06 Million - $4.07 Million
-29,848 Reduced 2.94%
985,397 $134 Million
Q1 2023

May 18, 2023
BUY
$89.75 - $107.27 $3.34 Million - $3.99 Million
37,231 Added 3.81%
1,015,245 $105 Million
Q1 2023

May 11, 2023
BUY
$89.75 - $107.27 $5.75 Million - $6.88 Million
64,120 Added 7.02%
978,014 $102 Million
Q4 2022

Feb 13, 2023
BUY
$72.84 - $94.04 $2.61 Million - $3.37 Million
35,784 Added 4.08%
913,894 $81 Million
Q3 2022

Nov 14, 2022
SELL
$77.78 - $103.92 $8.64 Million - $11.5 Million
-111,056 Reduced 11.23%
878,110 $70.4 Million
Q2 2022

Aug 11, 2022
BUY
$88.23 - $154.18 $13.5 Million - $23.6 Million
152,985 Added 18.3%
989,166 $94.7 Million
Q1 2022

May 11, 2022
BUY
$121.88 - $150.0 $535,906 - $659,550
4,397 Added 0.53%
836,181 $124 Million
Q4 2021

Feb 10, 2022
SELL
$129.86 - $157.03 $7.73 Million - $9.35 Million
-59,523 Reduced 6.68%
831,784 $118 Million
Q3 2021

Nov 12, 2021
BUY
$122.87 - $139.12 $110 Million - $124 Million
891,307 New
891,307 $117 Million

Others Institutions Holding CNMD

# of Institutions
299
Shares Held
36M
Call Options Held
119K
Put Options Held
5.1K
View Full List

About CONMED Corp

CNMD Quotes by TradingView
  • Ticker CNMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 30,482,400
  • Market Cap $1.87B
  • Description
  • CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...
More about CNMD
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email